Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model.
Clin Res Hepatol Gastroenterol
; 46(4): 101853, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-34923183
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Clin Res Hepatol Gastroenterol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: